Selected research
Industry Research
Pharmaceuticals Laboratory Service Industry Research Report 2026
Market perspective
The global Pharmaceuticals Laboratory Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceuticals Laboratory Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceuticals Laboratory Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceuticals Laboratory Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceuticals Laboratory Service include Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical and Intertek Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceuticals Laboratory Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceuticals Laboratory Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceuticals Laboratory Service Market by Company
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
DYNALABS
ADPEN Laboratories
ARL Bio Pharma
West Pharmaceutical
Microbac
Element (Analytical Lab Group)
Piramal Pharma Solutions
CTI
Weipu
PONY Medicine
Pharmaceuticals Laboratory Service Segment by Type
Raw Material Testing
Microbiological Testing
Drug Packaging Material Testing
Biological Analysis and Testing
Other
Pharmaceuticals Laboratory Service Segment by Application
CRO
CMO and CDMO
Finished Drugs and Environment
Pharmaceuticals Laboratory Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals Laboratory Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals Laboratory Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals Laboratory Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceuticals Laboratory Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Raw Material Testing
- Microbiological Testing
- Drug Packaging Material Testing
- Biological Analysis and Testing
- Other
Applications
- CRO
- CMO and CDMO
- Finished Drugs and Environment
Companies covered
- Eurofins
- WuXi AppTec
- Pace Analytical Services
- Catalent
- LabCorp (Covance)
- PPD
- Element (Exova)
- ALS Pharmaceutical
- Intertek Group
- SGS
- Boston Analytical
- DYNALABS
- ADPEN Laboratories
- ARL Bio Pharma
- West Pharmaceutical
- Microbac
- Element (Analytical Lab Group)
- Piramal Pharma Solutions
- CTI
- Weipu
- PONY Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceuticals Laboratory Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Raw Material Testing
- 2.2.3 Microbiological Testing
- 2.2.4 Drug Packaging Material Testing
- 2.2.5 Biological Analysis and Testing
- 2.2.6 Other
- 2.3 Pharmaceuticals Laboratory Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 CRO
- 2.3.3 CMO and CDMO
- 2.3.4 Finished Drugs and Environment
- 2.4 Assumptions and Limitations
3 Pharmaceuticals Laboratory Service Breakdown Data by Type
- 3.1 Global Pharmaceuticals Laboratory Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceuticals Laboratory Service Forecasted Market Size by Type (2027-2032)
4 Pharmaceuticals Laboratory Service Breakdown Data by Application
- 4.1 Global Pharmaceuticals Laboratory Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceuticals Laboratory Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceuticals Laboratory Service Market Perspective (2021-2032)
- 5.2 Global Pharmaceuticals Laboratory Service Growth Trends by Region
- 5.2.1 Global Pharmaceuticals Laboratory Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceuticals Laboratory Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceuticals Laboratory Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceuticals Laboratory Service Market Dynamics
- 5.3.1 Pharmaceuticals Laboratory Service Industry Trends
- 5.3.2 Pharmaceuticals Laboratory Service Market Drivers
- 5.3.3 Pharmaceuticals Laboratory Service Market Challenges
- 5.3.4 Pharmaceuticals Laboratory Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceuticals Laboratory Service Players by Revenue
- 6.1.1 Global Top Pharmaceuticals Laboratory Service Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceuticals Laboratory Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceuticals Laboratory Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceuticals Laboratory Service Head Office and Area Served
- 6.4 Global Pharmaceuticals Laboratory Service Players, Product Type & Application
- 6.5 Global Pharmaceuticals Laboratory Service Manufacturers Established Date
- 6.6 Global Pharmaceuticals Laboratory Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceuticals Laboratory Service Market Size (2021-2032)
- 7.2 North America Pharmaceuticals Laboratory Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceuticals Laboratory Service Market Size by Country (2021-2026)
- 7.4 North America Pharmaceuticals Laboratory Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceuticals Laboratory Service Market Size (2021-2032)
- 8.2 Europe Pharmaceuticals Laboratory Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceuticals Laboratory Service Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceuticals Laboratory Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceuticals Laboratory Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceuticals Laboratory Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceuticals Laboratory Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceuticals Laboratory Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceuticals Laboratory Service Market Size (2021-2032)
- 10.2 South America Pharmaceuticals Laboratory Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceuticals Laboratory Service Market Size by Country (2021-2026)
- 10.4 South America Pharmaceuticals Laboratory Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceuticals Laboratory Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceuticals Laboratory Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceuticals Laboratory Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceuticals Laboratory Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins
- 12.1.1 Eurofins Company Information
- 12.1.2 Eurofins Business Overview
- 12.1.3 Eurofins Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.1.4 Eurofins Pharmaceuticals Laboratory Service Product Portfolio
- 12.1.5 Eurofins Recent Developments
- 12.2 WuXi AppTec
- 12.2.1 WuXi AppTec Company Information
- 12.2.2 WuXi AppTec Business Overview
- 12.2.3 WuXi AppTec Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.2.4 WuXi AppTec Pharmaceuticals Laboratory Service Product Portfolio
- 12.2.5 WuXi AppTec Recent Developments
- 12.3 Pace Analytical Services
- 12.3.1 Pace Analytical Services Company Information
- 12.3.2 Pace Analytical Services Business Overview
- 12.3.3 Pace Analytical Services Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.3.4 Pace Analytical Services Pharmaceuticals Laboratory Service Product Portfolio
- 12.3.5 Pace Analytical Services Recent Developments
- 12.4 Catalent
- 12.4.1 Catalent Company Information
- 12.4.2 Catalent Business Overview
- 12.4.3 Catalent Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.4.4 Catalent Pharmaceuticals Laboratory Service Product Portfolio
- 12.4.5 Catalent Recent Developments
- 12.5 LabCorp (Covance)
- 12.5.1 LabCorp (Covance) Company Information
- 12.5.2 LabCorp (Covance) Business Overview
- 12.5.3 LabCorp (Covance) Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.5.4 LabCorp (Covance) Pharmaceuticals Laboratory Service Product Portfolio
- 12.5.5 LabCorp (Covance) Recent Developments
- 12.6 PPD
- 12.6.1 PPD Company Information
- 12.6.2 PPD Business Overview
- 12.6.3 PPD Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.6.4 PPD Pharmaceuticals Laboratory Service Product Portfolio
- 12.6.5 PPD Recent Developments
- 12.7 Element (Exova)
- 12.7.1 Element (Exova) Company Information
- 12.7.2 Element (Exova) Business Overview
- 12.7.3 Element (Exova) Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.7.4 Element (Exova) Pharmaceuticals Laboratory Service Product Portfolio
- 12.7.5 Element (Exova) Recent Developments
- 12.8 ALS Pharmaceutical
- 12.8.1 ALS Pharmaceutical Company Information
- 12.8.2 ALS Pharmaceutical Business Overview
- 12.8.3 ALS Pharmaceutical Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.8.4 ALS Pharmaceutical Pharmaceuticals Laboratory Service Product Portfolio
- 12.8.5 ALS Pharmaceutical Recent Developments
- 12.9 Intertek Group
- 12.9.1 Intertek Group Company Information
- 12.9.2 Intertek Group Business Overview
- 12.9.3 Intertek Group Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.9.4 Intertek Group Pharmaceuticals Laboratory Service Product Portfolio
- 12.9.5 Intertek Group Recent Developments
- 12.10 SGS
- 12.10.1 SGS Company Information
- 12.10.2 SGS Business Overview
- 12.10.3 SGS Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.10.4 SGS Pharmaceuticals Laboratory Service Product Portfolio
- 12.10.5 SGS Recent Developments
- 12.11 Boston Analytical
- 12.11.1 Boston Analytical Company Information
- 12.11.2 Boston Analytical Business Overview
- 12.11.3 Boston Analytical Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.11.4 Boston Analytical Pharmaceuticals Laboratory Service Product Portfolio
- 12.11.5 Boston Analytical Recent Developments
- 12.12 DYNALABS
- 12.12.1 DYNALABS Company Information
- 12.12.2 DYNALABS Business Overview
- 12.12.3 DYNALABS Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.12.4 DYNALABS Pharmaceuticals Laboratory Service Product Portfolio
- 12.12.5 DYNALABS Recent Developments
- 12.13 ADPEN Laboratories
- 12.13.1 ADPEN Laboratories Company Information
- 12.13.2 ADPEN Laboratories Business Overview
- 12.13.3 ADPEN Laboratories Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.13.4 ADPEN Laboratories Pharmaceuticals Laboratory Service Product Portfolio
- 12.13.5 ADPEN Laboratories Recent Developments
- 12.14 ARL Bio Pharma
- 12.14.1 ARL Bio Pharma Company Information
- 12.14.2 ARL Bio Pharma Business Overview
- 12.14.3 ARL Bio Pharma Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.14.4 ARL Bio Pharma Pharmaceuticals Laboratory Service Product Portfolio
- 12.14.5 ARL Bio Pharma Recent Developments
- 12.15 West Pharmaceutical
- 12.15.1 West Pharmaceutical Company Information
- 12.15.2 West Pharmaceutical Business Overview
- 12.15.3 West Pharmaceutical Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.15.4 West Pharmaceutical Pharmaceuticals Laboratory Service Product Portfolio
- 12.15.5 West Pharmaceutical Recent Developments
- 12.16 Microbac
- 12.16.1 Microbac Company Information
- 12.16.2 Microbac Business Overview
- 12.16.3 Microbac Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.16.4 Microbac Pharmaceuticals Laboratory Service Product Portfolio
- 12.16.5 Microbac Recent Developments
- 12.17 Element (Analytical Lab Group)
- 12.17.1 Element (Analytical Lab Group) Company Information
- 12.17.2 Element (Analytical Lab Group) Business Overview
- 12.17.3 Element (Analytical Lab Group) Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.17.4 Element (Analytical Lab Group) Pharmaceuticals Laboratory Service Product Portfolio
- 12.17.5 Element (Analytical Lab Group) Recent Developments
- 12.18 Piramal Pharma Solutions
- 12.18.1 Piramal Pharma Solutions Company Information
- 12.18.2 Piramal Pharma Solutions Business Overview
- 12.18.3 Piramal Pharma Solutions Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.18.4 Piramal Pharma Solutions Pharmaceuticals Laboratory Service Product Portfolio
- 12.18.5 Piramal Pharma Solutions Recent Developments
- 12.19 CTI
- 12.19.1 CTI Company Information
- 12.19.2 CTI Business Overview
- 12.19.3 CTI Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.19.4 CTI Pharmaceuticals Laboratory Service Product Portfolio
- 12.19.5 CTI Recent Developments
- 12.20 Weipu
- 12.20.1 Weipu Company Information
- 12.20.2 Weipu Business Overview
- 12.20.3 Weipu Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.20.4 Weipu Pharmaceuticals Laboratory Service Product Portfolio
- 12.20.5 Weipu Recent Developments
- 12.21 PONY Medicine
- 12.21.1 PONY Medicine Company Information
- 12.21.2 PONY Medicine Business Overview
- 12.21.3 PONY Medicine Revenue in Pharmaceuticals Laboratory Service Business (2021-2026)
- 12.21.4 PONY Medicine Pharmaceuticals Laboratory Service Product Portfolio
- 12.21.5 PONY Medicine Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst